Literature DB >> 15734610

A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging.

Cheuk-Man Yu1, Qing Zhang, Jeffrey Wing-Hong Fung, Hamish Chi-Kin Chan, Yat-Sun Chan, Gabriel Wai-Kwok Yip, Shun-Ling Kong, Hong Lin, Yan Zhang, John E Sanderson.   

Abstract

OBJECTIVES: This study was designed to investigate if tissue synchronization imaging (TSI) is useful to identify regional wall delay and predict left ventricular (LV) reverse remodeling after cardiac resynchronization therapy (CRT).
BACKGROUND: Echocardiographic assessment of systolic asynchrony is helpful to predict a positive response to CRT. Tissue synchronization imaging is a new imaging technique that allows quick evaluation of regional systolic delay.
METHODS: Tissue synchronization imaging was performed in 56 heart failure patients at baseline and three months after CRT. Regional wall delay was identified on TSI images and the time to regional peak systolic velocity (Ts) in LV was measured by the six-basal-six-mid-segmental model. Eight TSI parameters of systolic asynchrony were computed when Ts was measured in ejection phase or also included postsystolic shortening.
RESULTS: Severe lateral wall delay occurred in 17 patients, which predicted LV reverse remodeling (chi-square = 8.13, p = 0.004). Among the eight quantitative parameters of asynchrony, the predictive values were higher for parameters that measured Ts in ejection phase than in postsystolic shortening. The standard deviation of Ts of 12 LV segments in ejection phase (Ts-SD-12-ejection) was most powerful to predict reverse remodeling (r = -0.61, p < 0.001) and gain in ejection fraction (r = 0.53, p < 0.001). The area of the receiver-operating characteristic (ROC) curve was the largest for Ts-SD-12-ejection (0.90, p < 0.001), with a sensitivity of 87% and specificity of 81% at a cutoff of 34.4 ms. The combination of lateral wall delay with Ts-SD-12-ejection gave a sensitivity and specificity of 82% and 87%.
CONCLUSIONS: Tissue synchronization imaging allows quick evaluation of regional wall delay, and combined with Ts-SD-12-ejection provides a reliable way of predicting reverse remodeling after CRT.

Entities:  

Mesh:

Year:  2005        PMID: 15734610     DOI: 10.1016/j.jacc.2004.12.003

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  84 in total

1.  Intra-left ventricular systolic asynchrony in patients with overt hyperthyroidism.

Authors:  Abdulkadir Kırış; Cihangir Erem; Gülhanım Kırış; Mustafa Koçak; Omer Gedikli; Irfan Nuhoğlu; Merih Kutlu; Tuba Kaplan; Mustafa Gökçe; Sükrü Celik
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 2.  Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure.

Authors:  S Ellery; L Williams; M Frenneaux
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 3.  Echocardiographic methods to select candidates for cardiac resynchronisation therapy.

Authors:  Frank A Flachskampf; Jens-Uwe Voigt
Journal:  Heart       Date:  2006-03       Impact factor: 5.994

4.  Visualization of the site of the onset of ventricular depolarization by acceleration mode Tissue Doppler imaging technique.

Authors:  Yuksel Cavusoglu; Necmi Ata; Bilgin Timuralp; Alparslan Birdane; Bulent Gorenek; Ahmet Unalir
Journal:  Int J Cardiovasc Imaging       Date:  2005-10-20       Impact factor: 2.357

5.  Tissue synchronisation imaging accurately measures left ventricular dyssynchrony and predicts response to cardiac resynchronisation therapy.

Authors:  Nico R Van de Veire; Gabe B Bleeker; Johan De Sutter; Claudia Ypenburg; Eduard R Holman; Ernst E van der Wall; Ernst E van der Wal; Martin J Schalij; Jeroen J Bax
Journal:  Heart       Date:  2007-02-19       Impact factor: 5.994

6.  Tissue Doppler velocity is superior to displacement and strain mapping in predicting left ventricular reverse remodelling response after cardiac resynchronisation therapy.

Authors:  C-M Yu; Q Zhang; Y-S Chan; C-K Chan; G W K Yip; L C C Kum; E B Wu; P-W Lee; Y-Y Lam; S Chan; J W-H Fung
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

Review 7.  Current role of echocardiography in cardiac resynchronization therapy.

Authors:  Donato Mele; Matteo Bertini; Michele Malagù; Marianna Nardozza; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 8.  Cardiac resynchronization therapy.

Authors:  Brian T Schuler; Angel R León
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

9.  Left ventricular synchronicity is impaired in patients with active acromegaly.

Authors:  Abdulkadir Kırış; Cihangir Erem; Oğuzhan Ekrem Turan; Nadim Civan; Gülhanım Kırış; Irfan Nuhoğlu; Abdulselam Ilter; Halil Onder Ersöz; Merih Kutlu
Journal:  Endocrine       Date:  2012-12-20       Impact factor: 3.633

10.  Association of corrected QT dispersion with symptoms improvement in patients receiving cardiac resynchronization therapy.

Authors:  Kazuyoshi Hina; Hiroshi Kawamura; Takashi Murakami; Keizo Yamamoto; Hirosuke Yamaji; Masaaki Murakami; Satoshi Hirohata; Hiroko Ogawa; Kohsuke Sakane; Shozo Kusachi
Journal:  Heart Vessels       Date:  2008-09-20       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.